FGF21 elevation is a biomarker of citrin deficiency and its metabolic dysregulation in pediatric patients.

Liang J, Chu V, Che E, Kwok A, Belaramani K, Wu H, Law T, Kwok Y, Yeung C, Mak C, Wong S, Lam S, Yu F, Luk HM, Lau N, Wong F, Brenner C, Fung CW

Open source

DOI
10.1016/j.ymgme.2026.110262
Published
2026 Sep 18
Container
Molecular genetics and metabolism
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ymgme.2026.110262,
  title = {FGF21 elevation is a biomarker of citrin deficiency and its metabolic dysregulation in pediatric patients.},
  author = {Liang J and Chu V and Che E and Kwok A and Belaramani K and Wu H and Law T and Kwok Y and Yeung C and Mak C and Wong S and Lam S and Yu F and Luk HM and Lau N and Wong F and Brenner C and Fung CW},
  year = {2026},
  journal = {Molecular genetics and metabolism},
  doi = {10.1016/j.ymgme.2026.110262},
  url = {https://doi.org/10.1016/j.ymgme.2026.110262}
}

RIS

TY  - JOUR
TI  - FGF21 elevation is a biomarker of citrin deficiency and its metabolic dysregulation in pediatric patients.
AU  - Liang J
AU  - Chu V
AU  - Che E
AU  - Kwok A
AU  - Belaramani K
AU  - Wu H
AU  - Law T
AU  - Kwok Y
AU  - Yeung C
AU  - Mak C
AU  - Wong S
AU  - Lam S
AU  - Yu F
AU  - Luk HM
AU  - Lau N
AU  - Wong F
AU  - Brenner C
AU  - Fung CW
PY  - 2026
JO  - Molecular genetics and metabolism
DO  - 10.1016/j.ymgme.2026.110262
UR  - https://doi.org/10.1016/j.ymgme.2026.110262
ER  - 

APA

J, L., V, C., E, C., A, K., K, B., H, W., T, L., Y, K., C, Y., C, M., S, W., S, L., F, Y., HM, L., N, L., F, W., C, B., & CW, F. (2026). FGF21 elevation is a biomarker of citrin deficiency and its metabolic dysregulation in pediatric patients.. Molecular genetics and metabolism. https://doi.org/10.1016/j.ymgme.2026.110262

Source records